Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

Nova Scotia's colorectal cancer screening program sends kits to all Nova Scotians aged 50 to 74 every two years. It is aimed at early detection and prevention. The strategy has inspired copies ...

ntu.edu.tw Objective To measure the effects of faecal immunochemical test (FIT) for colorectal cancer (CRC) screening on overall and site-specific long-term effectiveness of population-based organised ...

One of Nova Scotia's cancer screening strategies may be getting revamped thanks to students at NSCAD University in Halifax. Nova Scotia's colorectal cancer screening program sends kits to all Nova ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your ...

In preliminary data, the test has demonstrated ‘promising’ specificity and sensitivity in detecting early-stage colorectal cancer ... on the ColoAlert test kit, contingent upon FDA approval ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...